|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Schouten, Philip C.; Richters, Lisa; Vis, Daniel J.; Kommoss, Stefan; Dijk, Ewald van; Ernst, Corinna; Kluin, Roelof J. C.; Marme, Frederik; Lips, Esther H.; Schmidt, Sandra; Scheerman, Esther; Prieske, Katharina; Deurzen, Carolien H. M. van; Burges, Alexander; Ewing-Graham, Patricia C.; Dietrich, Dimo; Jager, Agnes; De Gregorio, Nikolaus; Hauke, Jan; Du Bois, Andreas; Nederlof, Petra M.; Wessels, Lodewyk F.; Hahnen, Eric; Harter, Philipp; Linn, Sabine C. und Schmutzler, Rita K.
(2021):
Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial.
In: Clinical Cancer Research, Bd. 27, Nr. 23: S. 6559-6569
Montemurro, Filippo; Ellis, Paul; Anton, Antonio; Wuerstlein, Rachel; Delaloge, Suzette; Bonneterre, Jacques; Quenel-Tueux, Nathalie; Linn, Sabine C.; Irahara, Natsumi; Donica, Margarita; Lindegger, Nicolas und Barrios, Carlos H.
(2019):
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.
In: European Journal of Cancer, Bd. 109: S. 92-102
Schouten, Philip C.; Gluz, Oleg; Harbeck, Nadia; Mohrmann, Svjetlana; Diallo-Danebrock, Raihana; Pelz, Enrico; Kruizinga, Janneke; Velds, Arno; Nieuwland, Marja; Kerkhoven, Ron M.; Liedtke, Cornelia; Frick, Markus; Kates, Ronald; Linn, Sabine C.; Nitz, Ulrike und Marme, Frederik
(2016):
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
In: International Journal of Cancer, Bd. 139, Nr. 4: S. 882-889